Development of high drug-loading nanomicelles targeting steroids to the brain

Por Zheng, Sijia, Xie, Yanqi, Li, Yuan, Li, Ling, Tian, Ning, Zhu, Wenbo, Yan, Guangmei, Wu, Chuanbin, Hu, Haiyan
Publicado em 2013

PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis

Por XU, XIN, XIE, YANQI, LIN, YIWEI, XU, XIANGLAI, ZHU, YI, MAO, YEQING, HU, ZHENGHUI, WU, JIAN, CHEN, HONG, ZHENG, XIANGYI, QIN, JIE, XIE, LIPING
Publicado em 2012

Developing Antineoplastic Agents that Targeting Peroxisomal Enzymes: Cytisine-linked Isoflavonoids as Inhibitors of Hydroxysteroid 17-beta-dehydrogenase-4 (HSD17B4)

Por Frasinyuk, Mykhaylo S., Zhang, Wen, Wyrebek, Przemyslaw, Yu, Tianxin, Xu, Xuehe, Sviripa, Vitaliy M., Bondarenko, Svitlana P., Xie, Yanqi, Ngo, Huy X., Morris, Andrew J., Mohler, James L., Fiandalo, Michael V., Watt, David S., Liu, Chunming
Publicado no Org Biomol Chem (2017)